Route 92 Medical, Inc.

Route 92 Medical develops catheter-based medical devices for neurovascular intervention, with a focus on procedural access and stroke-related procedures. Its portfolio includes the FreeClimb catheter systems, powered by Tenzing, and the HiPoint Reperfusion System. The company states that the HiPoint system is investigational and that the SUMMIT MAX trial is evaluating its safety and efficacy.